HEPAFAT-SCAN® FATTY LIVER STUDY COMMENCES IN THE USA
- 21 August 2015
We are excited to announce that the paediatric fatty liver disease study using HepaFat-Scan has now commenced in the USA. It is being run in collaboration with the prestigious children’s hospital, Children’s Healthcare of Atlanta. At the date of this release, approximately ten patients have already been recruited and had HepaFat-Scans completed for the study, which commenced last month.
Entrepreneur of the Year Award - Western Region Technology Winner!
- 29 July 2015
Congratulations to our Chief Scientific Officer, Professor Tim St Pierre, for winning the Technology category of the Western Region EY Entrepreneur of the Year™ award on behalf of Resonance Health!
Conference Update: China Symposium on NAFLD in Shanghai
- 23 July 2015
The symposia on Non-alcoholic Fatty Liver Disease (NAFLD) in Shanghai was co-organised by the China Medical Association and Zhongshan Hospital Fudan University, chaired by Prof Gao Xin.
Conference Update: Showcasing Resonance Health in Europe
- 14 July 2015
Resonance Health attended or exhibited at three conferences in Europe in June 2015. We profiled both our FerriScan® and HepaFat-Scan® technologies to thousands of delegates and generated almost a hundred leads from around the world.
Resonance Health News June 2015
- 19 June 2015
Welcome to our June 2015 newsletter. In this issue we have some latest news from the clinical community, details of exciting developments in our R&D department and some new Resonance Health faces to introduce.
To read the full newsletter please click here
LIC-NET Italy Advances Best Practice in Iron Monitoring
- 19 June 2015
Headed by Professor Aurelio Maggio (Director of the Department of Haematology and Oncology at Villa Sofia-Cervello Hospital, Palermo, Italy) the Liver Iron Cutino Network (LIC-NET) is a growing network of 12 Italian hospitals working to improve the management of iron overload in patients through accurate assessment of liver iron concentration.